Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.50 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.37 |
| ▸ | DGKA | P23743 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 5/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | PAM | P19021 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL515199 | 0.93 | TSHR (0.43) | TSHRDGKACYP1A2LMNAALDH1A1 | |
| SCHEMBL687820 | 0.90 | DGKA (0.42) | TSHRDGKALMNAALDH1A1PAM | |
| SCHEMBL2762078 | 0.90 | DGKA (0.42) | TSHRDGKALMNAALDH1A1PAM | |
| SCHEMBL7945150 | 0.90 | DGKA (0.42) | TSHRDGKALMNAALDH1A1PAM | |
| SCHEMBL688762 | 0.90 | DGKA (0.42) | TSHRDGKALMNAALDH1A1PAM | |
| SCHEMBL7627037 | 0.86 | TSHR (0.44) | TSHRLMNAALDH1A1 | |
| SCHEMBL2447888 | 0.85 | — | — | |
| SCHEMBL374146 | 0.85 | — | — | |
| SCHEMBL931669 | 0.83 | — | — | |
| SCHEMBL19774445 | 0.83 | TSHR (0.48) | TSHRDGKALMNAALDH1A1PAM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 246 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118949709-A | Composite nanofiltration membrane, preparation method and application thereof in phosphoric acid purification | 华中科技大学 | 2024-11-15 | — | — | CN | claimed |
| US-6075139-A | ADDING DROPWISE A WATER IMMISCIBLE ORGANIC SOLVENT CONTAINING A BIFUNCTIONAL ACIDIC REACTANT TO AQUEOUS SOLUTION OF SUCROSE, AND MAINTAINING REACTION UNTIL SUCROSE ESTER OLIGOMER OR POLYMER IS PRODUCED AT INTERFACE | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2000-06-13 | — | — | US | claimed |
| WO-1998003528-A1 | LINEAR AND CYCLIC SUCROSE REACTION PRODUCTS, THEIR PREPARATION AND THEIR USE | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 1998-01-29 | — | — | WO | claimed |
| US-5141747-A | Repairing the tympanic membrane with coupled and modified collagen using radiation and lysine-reactive compounds; nontoxic; tensile strength | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1992-08-25 | — | — | US | claimed |
| US-4277576-A | Preparation of modified polymers of N-vinylpyrrolid-2-one and their use for the preparation of polymers interrupted by bridge members | BASF AKTIENGESELLSCHAFT (DE) | 1981-07-07 | — | — | US | claimed |
| US-20260117059-A1 | CURABLE RESIN, CURABLE RESIN COMPOSITION, CURED PRODUCT, PREPREG, LAMINATE, AND SEMICONDUCTOR SUBSTRATE | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2026-04-30 | — | — | US | disclosed |
| US-20260109854-A1 | CURABLE RESIN COMPOSITION, AND CURED PRODUCT THEREOF | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2026-04-23 | — | — | US | disclosed |
| US-20260109853-A1 | CURABLE RESIN COMPOSITION AND CURED PRODUCT OF SAME | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2026-04-23 | — | — | US | disclosed |
| US-20260078208-A1 | COMPOUND, CURABLE RESIN COMPOSITION AND CURED PRODUCT OF SAME | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2026-03-19 | — | — | US | disclosed |
| EP-4572882-A1 | PROCESS FOR PRODUCING MICROPARTICLES | BASF SE (DE) | 2025-06-25 | — | — | EP | disclosed |
| US-20250179243-A1 | MAIN CHAIN POLYMER, OPTICAL FILM, METHOD FOR PRODUCING MAIN CHAIN POLYMER, METHOD FOR PRODUCING OPTICAL FILM, AND MULTILAYER FILM | TOSOH CORPORATION (JP) | 2025-06-05 | — | — | US | disclosed |
| CN-119730951-A | Method for producing microparticles | 巴斯夫欧洲公司 | 2025-03-28 | — | — | CN | disclosed |
| US-4118397-A | DIURETICS | HOECHST AKTIENGESELLSCHAFT (DE) | 1978-10-03 | — | — | US | disclosed |
| US-4118232-A | Photographic material containing sulphonic acid group containing disazo dyestuffs | CIBA-GEIGY AG (CH) | 1978-10-03 | — | — | US | disclosed |
| US-4111953-A | DIURETICS | HOECHST AKTIENGESELLSCHAFT (DE) | 1978-09-05 | — | — | US | disclosed |
| US-4093735-A | DIURETICS | HOECHST AKTIENGESELLSCHAFT (DT) | 1978-06-06 | — | — | US | disclosed |
| US-4051123-A | Sulfonic-acid-group containing disazo dyestuffs | CIBA-GEIGY AG (CH) | 1977-09-27 | — | — | US | disclosed |
| US-4010273-A | DIURETICS, SALURETICS | HOECHST AKTIENGESELLSCHAFT (DT) | 1977-03-01 | — | — | US | disclosed |
| US-3956402-A | MICROBIOCIDES | CIBA-GEIGY CORPORATION (US) | 1976-05-11 | — | — | US | disclosed |
| US-3931142-A | Heterocyclic containing disazo compounds | CIBA-GEIGY AG (CH) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260109854-A1 | CURABLE RESIN COMPOSITION, AND CURED PRODUCT THEREOF | MLLT1, CRBN, POT1 | TSHR 4117/4885SLC22A6 4629/4885DGKA 4461/4885 |
| US-20260117059-A1 | CURABLE RESIN, CURABLE RESIN COMPOSITION, CURED PRODUCT, PREPREG, LAMINATE, AND SEMICONDUCTOR SUBSTRATE | RAD51, ASH2L, H1-0 | TSHR 4385/4885SLC22A6 4538/4885DGKA 4765/4885 |
| US-20260078208-A1 | COMPOUND, CURABLE RESIN COMPOSITION AND CURED PRODUCT OF SAME | BMI1, SEM1, PSMB2 | TSHR 3375/4885SLC22A6 4411/4885DGKA 4023/4885 |
| US-20250179243-A1 | MAIN CHAIN POLYMER, OPTICAL FILM, METHOD FOR PRODUCING MAIN CHAIN POLYMER, METHOD FOR PRODUCING OPTICAL FILM, AND MULTILAYER FILM | C9, RNF4, F12 | TSHR 2163/4885SLC22A6 4301/4885DGKA 4102/4885 |
| US-20260109853-A1 | CURABLE RESIN COMPOSITION AND CURED PRODUCT OF SAME | PSMA1, PSMB10, RAD51 | TSHR 4166/4885SLC22A6 4803/4885DGKA 4073/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.